NCT06491303 Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy Status NOT_YET_RECRUITING Phase N/A
NCT06433830 Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy Status RECRUITING Phase PHASE2
NCT06349577 Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury Status RECRUITING Phase NA
NCT06291415 The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE1
NCT06245746 UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia Status RECRUITING Phase PHASE1
NCT06202625 Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT Status RECRUITING Phase PHASE2/PHASE3
NCT06187831 Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger Status COMPLETED Phase N/A
NCT06095648 Study Comparing Platelet Transfusion Volumes in Premature Babies Status NOT_YET_RECRUITING Phase NA
NCT06036966 The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients Status UNKNOWN Phase PHASE2
NCT06001567 Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC Status UNKNOWN Phase PHASE2
NCT05998759 Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia Status RECRUITING Phase PHASE2
NCT05958511 Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients Status UNKNOWN Phase N/A
NCT05944809 The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients Status COMPLETED Phase PHASE2
NCT05944458 Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients Status COMPLETED Phase PHASE4
NCT05711485 Platelet-Directed Whole Blood Transfusion Strategy for Malaria Status RECRUITING Phase NA
NCT05672420 Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT05634005 Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence Status COMPLETED Phase NA